Transgenomic, Inc. (TBIO) Files Application For The NASDAQ Capital Market Listing And Board Approves Reverse Stock Split Ratio
1/16/2014 9:14:37 AM
OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced that it has filed an application for listing its common shares on The NASDAQ Capital Market.
Help employers find you! Check out all the jobs and post your resume.
comments powered by